Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.

Feighner JP, Boyer WF, Merideth CH, Hendrickson GG.

Int Clin Psychopharmacol. 1989 Apr;4(2):127-34.

PMID:
2663975
2.

Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.

Byerley WF, Reimherr FW, Wood DR, Grosser BI.

J Clin Psychopharmacol. 1988 Apr;8(2):112-5.

PMID:
3286684
3.

Fluoxetine in depressed patients: a comparison with imipramine.

Bremner JD.

J Clin Psychiatry. 1984 Oct;45(10):414-9.

PMID:
6384203
4.

A double-blind study of fluoxetine and imipramine in major depression.

Bressa GM, Brugnoli R, Pancheri P.

Int Clin Psychopharmacol. 1989 Jan;4 Suppl 1:69-73.

PMID:
2783701
5.

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.

Nielsen BM, Behnke K, Arup P, Christiansen PE, Geisler A, Ipsen E, Maach-Møller B, Ohrberg SC.

Acta Psychiatr Scand. 1993 Apr;87(4):269-72.

PMID:
8488748
6.
7.

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.

Muijen M, Roy D, Silverstone T, Mehmet A, Christie M.

Acta Psychiatr Scand. 1988 Sep;78(3):384-90.

PMID:
3057817
8.

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.

Cohn JB, Wilcox C.

J Clin Psychiatry. 1985 Mar;46(3 Pt 2):26-31.

PMID:
3882677
9.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
10.

Paroxetine in major depression: a double-blind trial with imipramine and placebo.

Cohn JB, Wilcox CS.

J Clin Psychiatry. 1992 Feb;53 Suppl:52-6.

PMID:
1531826
11.

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.

Cohn JB, Collins G, Ashbrook E, Wernicke JF.

Int Clin Psychopharmacol. 1989 Oct;4(4):313-22.

PMID:
2607128
12.

A double-blind comparison of paroxetine, imipramine, and placebo in major depression.

Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.

J Clin Psychiatry. 1992 Feb;53 Suppl:48-51.

PMID:
1531825
13.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
14.

A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.

Nemeroff CB, Thase ME; EPIC 014 Study Group..

J Psychiatr Res. 2007 Apr-Jun;41(3-4):351-9.

PMID:
16165158
15.

A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.

Feighner JP.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:31-5.

PMID:
1431008
16.

Onset of response in relation to outcome in depressed outpatients with placebo and imipramine.

Khan A, Cohen S, Dager S, Avery DH, Dunner DL.

J Affect Disord. 1989 Jul-Aug;17(1):33-8.

PMID:
2525576
17.

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.

Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA, Charney DS.

Biol Psychiatry. 1999 May 1;45(9):1170-7.

PMID:
10331109
18.

A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.

Fava M, Amsterdam JD, Deltito JA, Salzman C, Schwaller M, Dunner DL.

Ann Clin Psychiatry. 1998 Dec;10(4):145-50.

PMID:
9988054
19.
20.

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.

Akhondzadeh S, Faraji H, Sadeghi M, Afkham K, Fakhrzadeh H, Kamalipour A.

J Clin Pharm Ther. 2003 Oct;28(5):379-84.

PMID:
14632962
Items per page

Supplemental Content

Support Center